Xiaohui Zhang, md
Peking University People's Hospital, Peking University Insititute of Hematology
5
5
0
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Thomas Ortel, MD
Duke University
Shared therapeutic areas:
James Bussel, MD
Weill Medical College, Cornell University
Shared therapeutic areas:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Mohsen S Elalfy, professor
Ain Shams University
Shared therapeutic areas:
James George, MD
The University of Oklahoma
Shared therapeutic areas:
heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Jodi Segal, MD
Johns Hopkins University
Shared therapeutic areas:
Joseph Kiss, MD
University of Pittsburgh
Shared therapeutic areas:
Susan F Assmann, PhD
Carelon Research
Shared therapeutic areas:
William Wegener, MD, PhD
Gilead Sciences
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)
Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)
The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP
Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia
All 5 trials loaded